Bench-to-bedside and bedside back to the bench; seeking a better understanding of the acute pathophysiological process in severe traumatic brain injury

Frontiers in Neurology

Volumn 6, Issue MAR, 2015, Pages

  Agoston, Denes V ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Acute; Brain; Injury; Severe; Traumatic

Indexed keywords

CEREBROSPINAL FLUID; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; GLASGOW COMA SCALE; HUMAN; NEUROLOGIC EXAMINATION; NEUROMONITORING; PATHOPHYSIOLOGY; SHORT SURVEY; TRANSCRANIAL DOPPLER; TRAUMATIC BRAIN INJURY;

EID: 84926488499     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00047     Document Type: Short Survey

References (81)

1. Bruns J Jr, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia (2003) 44(Suppl 10):2-10. doi: 10.1046/j.1528-1157.44.s10.3.x
2. Mar J, Arrospide A, Begiristain JM, Larranaga I, Elosegui E, Oliva-Moreno J. The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life. BMC Neurol (2011) 11:46. doi:10.1186/1471-2377-11-46
3. Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien) (2006) 148(3):255-68. doi:10.1007/s00701-005-0651-y
4. Humphreys I, Wood RL, Phillips CJ, Macey S. The costs of traumatic brain injury: a literature review. Clinicoecon Outcomes Res (2013) 5:281-7. doi:10.2147/CEOR.S44625
5. Farhad K, Khan HM, Ji AB, Yacoub HA, Qureshi AI, Souayah N. Trends in outcomes and hospitalization costs for traumatic brain injury in adult patients in the United States. J Neurotrauma (2013) 30(2):84-90. doi:10.1089/neu.2011.2283
6. Ponsford JL, Spitz G, Cromarty F, Gifford D, Attwood D. Costs of care after traumatic brain injury. J Neurotrauma (2013) 30(17):1498-505. doi:10.1089/neu.2012.2843
7. Gavett BE, Stern RA, Cantu RC, Nowinski CJ, McKee AC. Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimers Res Ther (2010) 2(3):18. doi:10.1186/alzrt42
8. Jellinger KA. Traumatic brain injury as a risk factor for Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 75(3):511-2.
9. Sivanandam TM, Thakur MK. Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev (2012) 36(5):1376-81. doi:10.1016/j.neubiorev.2012.02.013
10. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT. Classification of traumatic brain injury for targeted therapies. J Neurotrauma (2008) 25(7):719-38. doi:10.1089/neu.2008.0586
11. Diaz-Arrastia R, Kochanek PM, Bergold P, Kenney K, Marx CE, Grimes CJ, et al. Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the department of defense neurotrauma pharmacology workgroup. J Neurotrauma (2014) 31(2):135-58. doi:10.1089/neu.2013.3019
12. Chowdhury T, Kowalski S, Arabi Y, Dash HH. General intensive care for patients with traumatic brain injury: an update. Saudi J Anaesth (2014) 8(2):256-63. doi:10.4103/1658-354X.130742
13. Elf K, Nilsson P, Enblad P. Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care. Crit Care Med (2002) 30(9):2129-34. doi:10.1097/00003246-200209000-00029
14. Haddad SH, Arabi YM. Critical care management of severe traumatic brain injury in adults. Scand J Trauma Resusc Emerg Med (2012) 20:12. doi:10.1186/1757-7241-20-12
15. Le Roux P. Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit. Curr Neurol Neurosci Rep (2013) 13(3):331. doi:10.1007/s11910-012-0331-2
16. Ling GS, Marshall SA. Management of traumatic brain injury in the intensive care unit. Neurol Clin (2008) 26(2):409-26. doi:10.1016/j.ncl.2008.02.001
17. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J Neurotrauma (2007) 24(Suppl 1):S37-44. doi:10.1089/neu.2007.9990
18. Sande A, West C. Traumatic brain injury: a review of pathophysiology and management. J Vet Emerg Crit Care (San Antonio) (2010) 20(2):177-90. doi:10.1111/j.1476-4431.2010.00527.x
19. Gold EM, Su D, Lopez-Velazquez L, Haus DL, Perez H, Lacuesta GA, et al. Functional assessment of long-term deficits in rodent models of traumatic brain injury. Regen Med (2013) 8(4):483-516. doi:10.2217/rme.13.41
20. Bigler ED. Quantitative magnetic resonance imaging in traumatic brain injury. J Head Trauma Rehabil (2001) 16(2):117-34. doi:10.1097/00001199-200104000-00003
21. Voelbel GT, Genova HM, Chiaravalotti ND, Hoptman MJ. Diffusion tensor imaging of traumatic brain injury review: implications for neurorehabilitation. NeuroRehabilitation (2012) 31(3):281-93. doi:10.3233/NRE-2012-0796
22. Xiong KL, Zhu YS, Zhang WG. Diffusion tensor imaging and magnetic resonance spectroscopy in traumatic brain injury: a review of recent literature. Brain Imaging Behav (2014) 8(4):487-96. doi:10.1007/s11682-013-9288-2
23. Ferris CF, Smerkers B, Kulkarni P, Caffrey M, Afacan O, Toddes S, et al. Functional magnetic resonance imaging in awake animals. Rev Neurosci (2011) 22(6):665-74. doi:10.1515/RNS.2011.050
24. Kim TH, Zollinger L, Shi XF, Rose J, Jeong EK. Diffusion tensor imaging of ex vivo cervical spinal cord specimens: the immediate and long-term effects of fixation on diffusivity. Anat Rec (Hoboken) (2009) 292(2):234-41. doi:10.1002/ar.20823
25. Lancelot S, Roche R, Slimen A, Bouillot C, Levigoureux E, Langlois JB, et al. A multi-atlas based method for automated anatomical rat brain MRI segmentation and extraction of PET activity. PLoS One (2014) 9(10):e109113. doi:10.1371/journal.pone.0109113
26. Oguz I, Zhang H, Rumple A, Sonka M. RATS: rapid automatic tissue segmentation in rodent brain MRI. J Neurosci Methods (2014) 221:175-82. doi:10.1016/j.jneumeth.2013.09.021
27. Papp EA, Leergaard TB, Calabrese E, Johnson GA, Bjaalie JG. Waxholm space atlas of the Sprague Dawley rat brain. Neuroimage (2014) 97:374-86. doi:10.1016/j.neuroimage.2014.04.001
28. Rumple A, McMurray M, Johns J, Lauder J, Makam P, Radcliffe M, et al. 3-dimensional diffusion tensor imaging (DTI) atlas of the rat brain. PLoS One (2013) 8(7):e67334. doi:10.1371/journal.pone.0067334
29. Matthews SC, Spadoni AD, Lohr JB, Strigo IA, Simmons AN. Diffusion tensor imaging evidence of white matter disruption associated with loss versus alteration of consciousness in warfighters exposed to combat in operations enduring and Iraqi freedom. Psychiatry Res (2012) 204(2-3):149-54. doi:10.1016/j.pscychresns.2012.04.018
30. Matthews SC, Strigo IA, Simmons AN, O'Connell RM, Reinhardt LE, Moseley SA. A multimodal imaging study in U.S. veterans of operations Iraqi and enduring freedom with and without major depression after blast-related concussion. Neuroimage (2011) 54(Suppl 1):S69-75. doi:10.1016/j.neuroimage.2010.04.269
31. Yan EB, Satgunaseelan L, Paul E, Bye N, Nguyen P, Agyapomaa D, et al. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury. J Neurotrauma (2014) 31(7):618-29. doi:10.1089/neu.2013.3087
32. Ahmed FA, Kamnaksh A, Kovesdi E, Long JB, Agoston DV. Long-term consequences of single and multiple mild blast exposure on select physiological parameters and blood-based biomarkers. Electrophoresis (2013) 34(15):2229-33. doi:10.1002/elps.201300077
33. Cernak I, Merkle AC, Koliatsos VE, Bilik JM, Luong QT, Mahota TM, et al. The pathobiology of blast injuries and blast-induced neurotrauma as identified using a new experimental model of injury in mice. Neurobiol Dis (2011) 41(2):538-51. doi:10.1016/j.nbd.2010.10.025
34. Dhawan V, DeGeorgia M. Neurointensive care biophysiological monitoring. J Neurointerv Surg (2012) 4(6):407-13. doi:10.1136/neurintsurg-2011-010158
35. Ko SB. Multimodality monitoring in the neurointensive care unit: a special perspective for patients with stroke. J Stroke (2013) 15(2):99-108. doi:10.5853/jos.2013.15.2.99
36. Hamm RJ, Jenkins LW, Lyeth BG, White-Gbadebo DM, Hayes RL. The effect of age on outcome following traumatic brain injury in rats. J Neurosurg (1991) 75(6):916-21. doi:10.3171/jns.1991.75.6.0916
37. Yuan XQ, Wade CE. Traumatic brain injury attenuates the effectiveness of lactated Ringer's solution resuscitation of hemorrhagic shock in rats. Surg Gynecol Obstet (1992) 174(4):305-12.
38. Bouzat P, Oddo M, Payen JF. Transcranial Doppler after traumatic brain injury: is there a role? Curr Opin Crit Care (2014) 20(2):153-60. doi:10.1097/MCC.0000000000000071
39. Salvadori A, Pasquier P, Jarrassier A, Schaal JV, Merat S. Transcranial Doppler to measure cerebral blood flow in management of traumatic brain injury. Injury (2013) 45:1801-2. doi:10.1016/j.injury.2012.08.059
40. Nuwer M. Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American academy of neurology and the American clinical neurophysiology society. Neurology (1997) 49(1):277-92. doi:10.1212/WNL.49.1.277
41. Jia X, Koenig MA, Shin HC, Zhen G, Pardo CA, Hanley DF, et al. Improving neurological outcomes post-cardiac arrest in a rat model: immediate hypothermia and quantitative EEG monitoring. Resuscitation (2008) 76(3):431-42. doi:10.1016/j.resuscitation.2007.08.014
42. Manley GT, Rosenthal G, Lam M, Morabito D, Yan D, Derugin N, et al. Controlled cortical impact in swine: pathophysiology and biomechanics. J Neurotrauma (2006) 23(2):128-39. doi:10.1089/neu.2006.23.128
43. Rosenthal G, Morabito D, Cohen M, Roeytenberg A, Derugin N, Panter SS, et al. Use of hemoglobin-based oxygen-carrying solution-201 to improve resuscitation parameters and prevent secondary brain injury in a swine model of traumatic brain injury and hemorrhage: laboratory investigation. J Neurosurg (2008) 108(3):575-87. doi:10.3171/JNS/2008/108/3/0575
44. Alvarez del Castillo M. Monitoring neurologic patients in intensive care. Curr Opin Crit Care (2001) 7(2):49-60. doi:10.1097/00075198-200104000-00001
45. Cecil S, Chen PM, Callaway SE, Rowland SM, Adler DE, Chen JW. Traumatic brain injury: advanced multimodal neuromonitoring from theory to clinical practice. Crit Care Nurse (2011) 31(2):25-36. doi:10.4037/ccn2010226
46. Hemphill JC, Andrews P, De Georgia M. Multimodal monitoring and neurocritical care bioinformatics. Nat Rev Neurol (2011) 7(8):451-60. doi:10.1038/nrneurol.2011.101
47. Vespa PM. Multimodality monitoring and telemonitoring in neurocritical care: from microdialysis to robotic telepresence. Curr Opin Crit Care (2005) 11(2):133-8. doi:10.1097/01.ccx.0000155353.01489.58
48. Agoston DV, Elsayed M. Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder. Front Neurol (2012) 3:107. doi:10.3389/fneur.2012.00107
49. Daoud H, Alharfi I, Alhelali I, Charyk Stewart T, Qasem H, Fraser DD. Brain injury biomarkers as outcome predictors in pediatric severe traumatic brain injury. Neurocrit Care (2013) 3:427-35. doi:10.1007/s12028-013-9879-1
50. Kobeissy FH, Sadasivan S, Oli MW, Robinson G, Larner SF, Zhang Z, et al. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Proteomics Clin Appl (2008) 2(10-11):1467-83. doi:10.1002/prca.200800011
51. Manley GT, Diaz-Arrastia R, Brophy M, Engel D, Goodman C, Gwinn K, et al. Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group. Arch Phys Med Rehabil (2010) 91(11):1667-72. doi:10.1016/j.apmr.2010.05.018
52. Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol (2013) 9(4):201-10. doi:10.1038/nrneurol.2013.9
53. Thelin EP, Johannesson LK, Nelson DW, Bellander BM. S100B is an important outcome predictor in traumatic brain injury. J Neurotrauma (2013) 30(7):519-28. doi:10.1089/neu.2012.2553
54. Thelin EP, Nelson DW, Bellander BM. Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury. Neurocrit Care (2013) 30:519-28. doi:10.1007/s12028-013-9916-0
55. Kochanek PM, Bell MJ, Bayir H. Quo vadis 2010? - carpe diem: challenges and opportunities in pediatric traumatic brain injury. Dev Neurosci (2010) 32(5-6):335-42. doi:10.1159/000323016
56. Hanrieder J, Wetterhall M, Enblad P, Hillered L, Bergquist J. Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods (2009) 177(2):469-78. doi:10.1016/j.jneumeth.2008.10.038
57. Neselius S, Brisby H, Theodorsson A, Blennow K, Zetterberg H, Marcusson J. CSF-biomarkers in olympic boxing: diagnosis and effects of repetitive head trauma. PLoS One (2012) 7(4):e33606. doi:10.1371/journal.pone.0033606
58. Petzold A. CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol Res (2007) 29(7):691-708. doi:10.1179/016164107X240080
59. Romeo MJ, Espina V, Lowenthal M, Espina BH, Petricoin EF III, Liotta LA. CSF proteome: a protein repository for potential biomarker identification. Expert Rev Proteomics (2005) 2(1):57-70. doi:10.1586/14789450.2.1.57
60. Cadosch D, Thyer M, Gautschi OP, Lochnit G, Frey SP, Zellweger R, et al. Functional and proteomic analysis of serum and cerebrospinal fluid derived from patients with traumatic brain injury: a pilot study. ANZ J Surg (2010) 80(7-8):542-7. doi:10.1111/j.1445-2197.2010.05268.x
61. Martinez-Morillo E, Garcia Hernandez P, Begcevic I, Kosanam H, Prieto Garcia B, Alvarez Menendez FV, et al. Identification of novel biomarkers of brain damage in patients with hemorrhagic stroke by integrating bioinformatics and mass spectrometry-based proteomics. J Proteome Res (2014) 13(2):969-81. doi:10.1021/pr401111h
62. Sjodin MO, Bergquist J, Wetterhall M. Mining ventricular cerebrospinal fluid from patients with traumatic brain injury using hexapeptide ligand libraries to search for trauma biomarkers. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 878(22):2003-12. doi:10.1016/j.jchromb.2010.05.036
63. Waybright TJ. Preparation of human cerebrospinal fluid for proteomics biomarker analysis. Methods Mol Biol (2013) 1002:61-70. doi:10.1007/978-1-62703-360-2_5
64. Mondello S, Linnet A, Buki A, Robicsek S, Gabrielli A, Tepas J, et al. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery (2012) 70(3):666-75. doi:10.1227/NEU.0b013e318236a809
65. Ahmed F, Gyorgy A, Kamnaksh A, Ling G, Tong L, Parks S, et al. Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury. Electrophoresis (2012) 33(24):3705-11. doi:10.1002/elps.201200299
66. Liu MC, Akinyi L, Scharf D, Mo J, Larner SF, Muller U, et al. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur J Neurosci (2010) 31(4):722-32. doi:10.1111/j.1460-9568.2010.07097.x
67. Tsitsopoulos PP, Marklund N. Amyloid-beta peptides and tau protein as biomarkers in cerebrospinal and interstitial fluid following traumatic brain injury: a review of experimental and clinical studies. Front Neurol (2013) 4:79. doi:10.3389/fneur.2013.00079
68. Bellander BM, Cantais E, Enblad P, Hutchinson P, Nordstrom CH, Robertson C, et al. Consensus meeting on microdialysis in neurointensive care. Intensive Care Med (2004) 30(12):2166-9. doi:10.1007/s00134-004-2461-8
69. de Lima Oliveira M, Kairalla AC, Fonoff ET, Martinez RC, Teixeira MJ, Bor-Seng-Shu E. Cerebral microdialysis in traumatic brain injury and subarachnoid hemorrhage: state of the art. Neurocrit Care (2013) 21:152-62. doi:10.1007/s12028-013-9884-4
70. Engstrom M, Polito A, Reinstrup P, Romner B, Ryding E, Ungerstedt U, et al. Intracerebral microdialysis in severe brain trauma: the importance of catheter location. J Neurosurg (2005) 102(3):460-9. doi:10.3171/jns.2005.102.3.0460
71. Hutchinson PJ. Microdialysis in traumatic brain injury - methodology and pathophysiology. Acta Neurochir Suppl (2005) 95:441-5. doi:10.1007/3-211-32318-X_91
72. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med (1991) 230(4):365-73. doi:10.1111/j.1365-2796.1991.tb00459.x
73. Ungerstedt U, Rostami E. Microdialysis in neurointensive care. Curr Pharm Des (2004) 10(18):2145-52. doi:10.2174/1381612043384105
74. Hillered L, Vespa PM, Hovda DA. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma (2005) 22(1):3-41. doi:10.1089/neu.2005.22.3
75. Korf J, Huinink KD, Posthuma-Trumpie GA. Ultraslow microdialysis and microfiltration for in-line, on-line and off-line monitoring. Trends Biotechnol (2010) 28(3):150-8. doi:10.1016/j.tibtech.2009.12.005
76. Lakshmanan R, Loo JA, Drake T, Leblanc J, Ytterberg AJ, McArthur DL, et al. Metabolic crisis after traumatic brain injury is associated with a novel microdialysis proteome. Neurocrit Care (2010) 12(3):324-36. doi:10.1007/s12028-010-9342-5
77. Quinn R. Comparing rat's to human's age: how old is my rat in people years? Nutrition (2005) 21(6):775-7. doi:10.1016/j.nut.2005.04.002
78. Andreollo NA, Santos EF, Araujo MR, Lopes LR. Rat's age versus human's age: what is the relationship? Arq Bras Cir Dig (2012) 25(1):49-51. doi:10.1590/S0102-67202012000100011
79. Sengupta P. The laboratory rat: relating its age with human's. Int J Prev Med (2013) 4(6):624-30.
80. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 110(9):3507-12. doi:10.1073/pnas.1222878110
81. Agoston DV. Of timescales, animal models, and human disease: the 50th anniversary of C. elegans as a biological model. Front Neurol (2013) 4:129. doi:10.3389/fneur.2013.00129